What are the most recent guidelines for managing hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Recent Guidelines for Managing Hypertension

The 2024 European Society of Cardiology (ESC) guidelines recommend a target systolic blood pressure of 120-129 mmHg for most adults with hypertension to reduce cardiovascular disease risk. 1

Diagnosis and Blood Pressure Measurement

  • Hypertension is defined as persistent systolic blood pressure (SBP) ≥140 mmHg or diastolic blood pressure (DBP) ≥90 mmHg
  • Multiple office BP measurements are the gold standard for diagnosis
  • Self-monitoring and ambulatory blood pressure monitoring (ABPM) can aid in diagnosis and long-term monitoring
  • BP exhibits seasonal variation with lower levels at higher temperatures and higher at lower temperatures (average decline of 5/3 mmHg systolic/diastolic in summer) 1

Treatment Thresholds

  1. Confirmed BP ≥140/90 mmHg: Prompt initiation of lifestyle measures and pharmacological treatment regardless of cardiovascular risk 1

  2. BP 130-139/80-89 mmHg:

    • After 3 months of lifestyle intervention, pharmacological treatment is recommended for those with high cardiovascular risk (≥10% 10-year risk) 1
    • The 2024 ESC guidelines expand this recommendation to include those with established CVD, hypertension-mediated organ damage, diabetes, moderate/severe CKD, or familial hypercholesterolemia 1

Treatment Targets

  • Most adults: Target SBP 120-129 mmHg 1
  • If poorly tolerated: Target "as low as reasonably achievable" (ALARA principle) 1
  • Special populations:
    • Adults ≥85 years: Consider more lenient target (BP <140/90 mmHg) 1
    • Patients with diabetes, renal impairment, or established CVD: Target BP ≤130/80 mmHg 1

Lifestyle Modifications

All patients with elevated BP should implement the following lifestyle changes:

  1. Diet:

    • Salt reduction (avoid added salt and high-sodium processed foods)
    • Mediterranean or DASH diet (rich in whole grains, fruits, vegetables, polyunsaturated fats)
    • Restrict free sugar consumption to <10% of energy intake
    • Avoid sugar-sweetened beverages 1
  2. Physical Activity:

    • Regular aerobic exercise (150-300 minutes/week of moderate-intensity or 75-150 minutes/week of vigorous-intensity)
    • Complement with resistance training 2-3 times/week 1
  3. Weight Management:

    • Aim for BMI 20-25 kg/m²
    • Waist circumference <94 cm in men and <80 cm in women 1
  4. Alcohol Consumption:

    • Limit to <100g/week of pure alcohol (approximately 2 standard drinks/day for men, 1.5 for women)
    • Preferably avoid alcohol consumption entirely 1
  5. Smoking Cessation:

    • Complete cessation recommended with referral to smoking cessation programs 1

Pharmacological Treatment

First-Line Medications

The following drug classes are recommended as first-line treatments 1, 2:

  • ACE inhibitors (e.g., lisinopril, ramipril)
  • ARBs (e.g., losartan, valsartan)
  • Dihydropyridine calcium channel blockers (e.g., amlodipine)
  • Thiazide/thiazide-like diuretics (e.g., chlorthalidone, indapamide)

Treatment Strategy

  1. Initial therapy: Combination BP-lowering treatment is recommended for most patients with confirmed hypertension (BP ≥140/90 mmHg) 1

    • Preferred combinations: RAS blocker (ACE inhibitor or ARB) with either a dihydropyridine CCB or diuretic
    • Fixed-dose single-pill combinations are recommended for better adherence
  2. If BP not controlled with two drugs: Add a third drug, typically a RAS blocker + dihydropyridine CCB + thiazide/thiazide-like diuretic, preferably as a single-pill combination 1

  3. Beta-blockers: Recommended when there are specific indications (angina, post-myocardial infarction, heart failure with reduced ejection fraction, or heart rate control) 1, 2

  4. Important caution: Combining two RAS blockers (ACE inhibitor and ARB) is not recommended 1

Special Populations

  1. Non-Black patients: Start with ACE inhibitor/ARB, add dihydropyridine CCB, then add thiazide/thiazide-like diuretic 2

  2. Black patients: Start with ARB plus CCB, or CCB plus thiazide diuretic 2

  3. Diabetes and CKD: First choice is ACE inhibitor or ARB 2

  4. Elderly patients (≥75 years): Target BP <140/90 mmHg, use simplified regimens, monitor for orthostatic hypotension 2

Common Pitfalls and Caveats

  1. Medication adherence: Poor adherence affects 10-80% of hypertensive patients and is a key driver of suboptimal BP control 1

    • Take medications at the most convenient time of day to establish a habitual pattern
    • Use fixed-dose combinations when possible
  2. Seasonal BP variation: Consider adjusting treatment during significant temperature changes, as BP tends to be higher in cold weather and lower in warm weather 1

  3. Medication interactions: Be cautious with NSAIDs (can reduce effectiveness of ACE inhibitors, ARBs, and diuretics) and potassium supplements (can increase risk of hyperkalemia with ACE inhibitors, ARBs, and aldosterone antagonists) 2

  4. Monitoring: Check renal function and potassium within 1-2 weeks of initiating ACE inhibitors and ARBs 2

  5. Lifelong treatment: BP-lowering drug treatment should be maintained lifelong, even beyond age 85, if well tolerated 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.